M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
iBio names Dr Richard M. Silver to clinical advisory board
Plant biotechnology company iBio (NYSE MKT:IBIO) revealed on Monday the addition of Dr Richard M. Silver, MD to its clinical advisory board.
In the new role, Dr Silver will guide the company in developing the clinical trial design for its novel drug candidate for systemic sclerosis and...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives